Brennan, Paul

Dr

  • 676 Citations
  • 6 h-Index
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paul Brennan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 676 Citations
  • 6 h-Index
  • 10 Article
  • 2 Letter
  • 2 Review article
  • 1 Editorial
Open Access
File
  • 16 Downloads (Pure)

    Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase

    Dex-CSDH trial collaborative and BNTRC collaborative, Edlmann, E., Thelin, E. P., Caldwell, K., Turner, C., Whitfield, P., Bulters, D., Holton, P., Suttner, N., Owusu-Agyemang, K., Al-Tamimi, Y. Z., Gatt, D., Thomson, S., Anderson, I. A., Richards, O., Gherle, M., Toman, E., Nandi, D., Kane, P., Pantaleo, B. & 14 others, Davis-Wilkie, C., Tarantino, S., Barton, G., Marcus, H. J., Chari, A., Belli, A., Bond, S., Gafoor, R., Dawson, S., Whitehead, L., Brennan, P., Wilkinson, I., Kolias, A. G. & Hutchinson, P. J. A., 10 Apr 2019, In : Scientific Reports. 9, p. 1-13 13 p., 5885.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 3 Citations (Scopus)
    111 Downloads (Pure)

    New Horizons in Hepatitis B and C in the Older Adult

    Kemp, L., Clare, K. E., Brennan, P. N. & Dillon, J. F., 1 Jan 2019, In : Age and Ageing. 48, 1, p. 32-37 6 p.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 41 Downloads (Pure)

    Nivolumab and immune-mediated colitis

    Walker, H., Brennan, P., Groome, M., Walsh, S. & Carey, F., 8 Apr 2019, In : Clinical Case Reports. 7, 4, p. 644-647 4 p.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 1 Citation (Scopus)
    103 Downloads (Pure)

    Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

    Plevris, N., Chuah, C. S., Allen, R. M., Arnott, I. D., Brennan, P. N., Chaudhary, S., Churchhouse, A. M. D., Din, S., Donoghue, E., Gaya, D. R., Groome, M., Jafferbhoy, H. M., Jenkinson, P. W., Lam, W. L., Lyons, M., Macdonald, J. C., MacMaster, M., Mowat, C., Naismith, G. D., Potts, L. F. & 11 others, Saffouri, E., Seenan, J. P., Sengupta, A., Shasi, P., Sutherland, D. I., Todd, J. A., Veryan, J., Watson, A. J. M., Watts, D., Jones, G. R. & Lees, C. W., Sep 2019, In : Journal of Crohn's and Colitis. 13, 9, p. 1111-1120 10 p.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 14 Citations (Scopus)
    42 Downloads (Pure)